Boston Scientific gets FDA approval for Liberté stent

Interventional device manufacturer Boston Scientific said that it has received Food and Drug Administration approval for its Liberté bare-metal coronary stent system.

The Liberté stent serves as the platform for Boston Scientific's paclitaxel-eluting stent system, Taxus Liberté. Boston Scientific plans to launch the Liberté stent immediately in the U.S., according to the Natick, MA-based firm.

By AuntMinnie.com staff writers
April 14, 2005

Related Reading

Boston Scientific initiates Syntax trial, April 12, 2005

Boston Scientific adds CE Mark, April 6, 2005

Boston Scientific gets FDA OK for Taxus in MRI, April 5, 2005

Boston Scientific loses stent verdict, March 25, 2005

Boston Scientific continues robust growth, February 1, 2005

Copyright © 2005 AuntMinnie.com

Page 1 of 180
Next Page